NorthRock Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $275K | Sell |
|
|||||
|
2025
Q2 | $469K | Sell |
|
|||||
|
2025
Q1 | $396K | Sell |
|
|||||
|
2024
Q4 | $595K | Buy |
|
|||||
|
2024
Q3 | $232K | Sell |
|
|||||
|
2024
Q2 | $562K | Buy |
|
|||||
|
2024
Q1 | $662K | Sell |
|
|||||
|
2023
Q4 | $595K | Buy |
|
|||||
|
2023
Q3 | $264K | Sell |
|
|||||
|
2023
Q2 | $412K | Sell |
|
|||||
|
2023
Q1 | $411K | Sell |
|
|||||
|
2022
Q4 | $457K | Buy |
|
|||||
|
2022
Q3 | $246K | Buy |
|
|||||
|
2022
Q2 | $216K | Buy |
|
|||||
|
2022
Q1 | $350K | Buy |
|
|||||
|
2021
Q4 | $363K | Buy |
|
|||||
|
2021
Q3 | $326K | Buy |
|
|||||
|
2021
Q2 | $207K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $231K | Buy |
|